nfants consuming human milk exhibit fewer symptomsof infection than those who do not. We have demonstrated that human milk glycans prevent infection by inhibiting the ability of enteric pathogens to bind to host ligands. These glycans include the unbound human milk oligosaccharides (HMOS) and larger glycoconjugates containing carbohydrate moieties with blood group antigens on the non-reducing terminus. In the current project, we will focus on other potentially major functions of human milk glycans in the ntestinal mucosa during infant development. We recently discovered that HMOS strongly quench inflammation of the gut, and that the microbiota in the lumen of the gut affects glycan expression on the mucosal cell surface. Our grand hypothesis is that HMOS provide several integrated layers of protection: 1) promote mucosal barriers that inhibit pathogen penetration to the mucosalcell surface, 2) inhibit binding by pathogens that do reach host mucosal cell surface receptors, 3) directly attenuate the host inflammatory response to pathogens,and 4) indirectly stimulate maturation of the mucosal innate immune system. This project investigates major protective mechanisms of human milk glycansthat may work in synergywith nhibition of pathogen adhesion, specifically, inhibition of inflammation in infant intestinal mucosa, promotion of colonization by symbiotic microbiota, and maturation of the infant mucosa and its innate immune system. This project will: Characterize the HMOS that directly suppress mucosal inflammation, and determine their mechanism of action. Investigate HMOS as prebiotics that modify the intestinal microbiota andthereby indirectly affect glycosylation and gut mucosal proinflammatory signaling. Determine the independent and interdependent effects of maternal milk fucosylglycansand infant gut fucosylglycanson the composition of the gut microbiota and risk of NEC and other enteric disease in infants. Test the ability of a synthetic human milk secretorfucosylglycanto suppress mucosalinflammation and to function as a prebiotic in preclinical studies. Understanding the multiple interactions of HMOS with the nascent infant mucosal immune system and with mutualist symbiotic bacteria will provide the basis for optimizing the design of therapeutic glycans to protect all infants, irrespective of their age of weaning.

Public Health Relevance

The research proposedin this application is designed to transform our fundamental understanding of human milk glycans as factors that promote beneficial bacteria and reduce inflammation in the gastrointestinal tract of breastfeeding infants and to translate our discoveries into new medications, food substances, and diagnostic toolsthat promote the health and survival of infants and children worldwide.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Program Projects (P01)
Project #
5P01HD013021-35
Application #
8514654
Study Section
Special Emphasis Panel (ZHD1-DSR-A)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
35
Fiscal Year
2013
Total Cost
$241,642
Indirect Cost
$25,376
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Newburg, David S; Grave, Gilman (2014) Recent advances in human milk glycobiology. Pediatr Res 75:675-9
Tan, Ming; Jiang, Xi (2014) Subviral particle as vaccine and vaccine platform. Curr Opin Virol 6:24-33
He, Y; Liu, S; Leone, S et al. (2014) Human colostrum oligosaccharides modulate major immunologic pathways of immature human intestine. Mucosal Immunol 7:1326-39
Farkas, Tibor; Lun, Cindy Wong Ping; Fey, Brittney (2014) Relationship between genotypes and serotypes of genogroup 1 recoviruses: a model for human norovirus antigenic diversity. J Gen Virol 95:1469-78
Tan, Ming; Jiang, Xi (2014) Vaccine against norovirus. Hum Vaccin Immunother 10:1449-56
Tan, Ming; Jiang, Xi (2014) Histo-blood group antigens: a common niche for norovirus and rotavirus. Expert Rev Mol Med 16:e5
Greenwood, Corryn; Morrow, Ardythe L; Lagomarcino, Anne J et al. (2014) Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter. J Pediatr 165:23-9
Van Trang, Nguyen; Vu, Hau ThiBich; Le, Nhung ThiHong et al. (2014) Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children. J Clin Microbiol 52:1366-74
Wang, Leyi; Xia, Ming; Huang, Pengwei et al. (2014) Branched-linear and agglomerate protein polymers as vaccine platforms. Biomaterials 35:8427-38
Lemay, Danielle G; Ballard, Olivia A; Hughes, Maria A et al. (2013) RNA sequencing of the human milk fat layer transcriptome reveals distinct gene expression profiles at three stages of lactation. PLoS One 8:e67531

Showing the most recent 10 out of 261 publications